Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$2.88M Buy
38,792
+53
+0.1% +$3.91K 0.77% 33
2020
Q4
$3.05M Sell
38,739
-324
-0.8% -$24.8K 0.85% 29
2020
Q3
$3.12M Sell
39,063
-259
-0.7% -$20.3K 0.96% 26
2020
Q2
$2.92M Buy
39,322
+5,873
+18% +$442K 0.98% 24
2020
Q1
$2.48M Sell
33,449
-524
-2% -$41.2K 1.03% 25
2019
Q4
$2.97M Hold
33,973
1.02% 26
2019
Q3
$2.75M Hold
33,973
1.02% 25
2019
Q2
$2.74M Sell
33,973
-49
-0.1% -$3.75K 1.02% 26
2019
Q1
$2.72M Sell
34,022
-151
-0.4% -$11.3K 1.01% 25
2018
Q4
$2.49M Sell
34,173
-122
-0.4% -$8.61K 1.03% 22
2018
Q3
$2.32M Buy
34,295
+65
+0.2% +$4.14K 0.82% 34
2018
Q2
$2M Buy
34,230
+129
+0.4% +$7.28K 0.76% 35
2018
Q1
$1.75M Buy
34,101
+4,010
+13% +$217K 0.71% 39
2017
Q4
$1.63M Sell
30,091
-36
-0.1% -$2K 0.67% 37
2017
Q3
$1.85M Buy
30,127
+174
+0.6% +$10.5K 0.8% 35
2017
Q2
$1.84M Hold
29,953
0.82% 37
2017
Q1
$1.78M Sell
29,953
-287
-0.9% -$17.4K 0.79% 40
2016
Q4
$1.85M Buy
30,240
+8,290
+38% +$485K 0.81% 39
2016
Q3
$1.31M Buy
+21,950
New +$1.28M 1.03% 35

Other funds holding MRK

Rikoon Group's MRK Position: Q1 2021 in Review

Rikoon Group increased its Merck (MRK) stake by 0.14% in Q1 2021, buying an estimated $3.91K and bringing the position to 38,792 shares worth $2.88M. The position accounts for 0.77% of the portfolio, ranked #33.

Rikoon Group first reported a position in MRK in Q3 2016 and has held it in 19 quarters since. The position peaked at $3.12M in Q3 2020. 2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Rikoon Group held 38,792 shares of Merck worth $2.88M as of Q1 2021.
  • Rikoon Group bought 53 Merck shares in Q1 2021, an estimated $3.91K.
  • Merck made up 0.77% of Rikoon Group's portfolio in Q1 2021, its #33 holding.
  • Rikoon Group first reported a position in Merck in Q3 2016 and has held it in 19 quarters since.
  • Rikoon Group's Merck position peaked at $3.12M in Q3 2020.
  • 2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.